Ingalls & Snyder LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Sell
74,952
-4,100
-5% -$955K 0.65% 36
2025
Q4
$16.4M Sell
79,052
-2,027
-3% -$401K 0.6% 39
2025
Q3
$15M Sell
81,079
-3,580
-4% -$613K 0.49% 41
2025
Q2
$12.9M Sell
84,659
-1,474
-2% -$227K 0.46% 43
2025
Q1
$14.3M Sell
86,133
-3,950
-4% -$618K 0.47% 39
2024
Q4
$13M Sell
90,083
-1,127
-1% -$175K 0.51% 39
2024
Q3
$14.8M Sell
91,210
-952
-1% -$152K 0.58% 38
2024
Q2
$13.5M Sell
92,162
-1,895
-2% -$282K 0.58% 39
2024
Q1
$14.9M Sell
94,057
-786
-0.8% -$125K 0.66% 39
2023
Q4
$14.9M Sell
94,843
-4,104
-4% -$629K 0.67% 36
2023
Q3
$15.4M Sell
98,947
-16,048
-14% -$2.65M 0.74% 28
2023
Q2
$19M Sell
114,995
-903
-0.8% -$146K 0.91% 26
2023
Q1
$18M Sell
115,898
-1,043
-0.9% -$168K 0.92% 28
2022
Q4
$20.7M Sell
116,941
-3,087
-3% -$533K 1.12% 21
2022
Q3
$19.6M Sell
120,028
-1,519
-1% -$257K 1.09% 22
2022
Q2
$21.6M Sell
121,547
-1,269
-1% -$226K 1.13% 20
2022
Q1
$21.8M Buy
122,816
+811
+0.7% +$138K 0.97% 23
2021
Q4
$20.9M Sell
122,005
-5,994
-5% -$981K 0.94% 28
2021
Q3
$20.7M Sell
127,999
-5,983
-4% -$1.02M 0.95% 28
2021
Q2
$22.1M Sell
133,982
-8,359
-6% -$1.38M 0.98% 26
2021
Q1
$23.4M Sell
142,341
-859
-0.6% -$139K 1.09% 23
2020
Q4
$22.5M Sell
143,200
-639
-0.4% -$94.3K 1.11% 20
2020
Q3
$21.4M Sell
143,839
-1,607
-1% -$238K 1.47% 17
2020
Q2
$20.5M Buy
145,446
+281
+0.2% +$41K 1.17% 19
2020
Q1
$19M Sell
145,165
-7,517
-5% -$1.07M 1.28% 17
2019
Q4
$22.3M Sell
152,682
-738
-0.5% -$100K 1.21% 20
2019
Q3
$19.8M Sell
153,420
-23,623
-13% -$3.11M 0.97% 25
2019
Q2
$24.7M Sell
177,043
-1,524
-0.9% -$211K 1.19% 18
2019
Q1
$25M Sell
178,567
-2,105
-1% -$282K 1.19% 16
2018
Q4
$23.3M Sell
180,672
-2,829
-2% -$395K 1.23% 16
2018
Q3
$25.4M Sell
183,501
-1,509
-0.8% -$201K 1.07% 17
2018
Q2
$22.4M Buy
185,010
+4,723
+3% +$589K 1.04% 20
2018
Q1
$23.1M Sell
180,287
-1,844
-1% -$249K 1.13% 20
2017
Q4
$25.4M Sell
182,131
-4,735
-3% -$660K 1.17% 17
2017
Q3
$24.3M Sell
186,866
-4,165
-2% -$552K 1.27% 15
2017
Q2
$25.3M Buy
191,031
+2,600
+1% +$332K 1.37% 15
2017
Q1
$23.5M Buy
188,431
+3,332
+2% +$398K 1.25% 18
2016
Q4
$21.3M Sell
185,099
-2,167
-1% -$250K 1.16% 23
2016
Q3
$22.1M Sell
187,266
-4,289
-2% -$520K 1.23% 19
2016
Q2
$23.2M Sell
191,555
-2,849
-1% -$324K 1.37% 18
2016
Q1
$21M Sell
194,404
-6,561
-3% -$679K 1.34% 22
2015
Q4
$20.6M Sell
200,965
-3,146
-2% -$316K 1.32% 19
2015
Q3
$19.1M Buy
204,111
+2,496
+1% +$241K 1.25% 19
2015
Q2
$19.6M Buy
201,615
+5,471
+3% +$548K 1.08% 23
2015
Q1
$19.7M Sell
196,144
-1,198
-0.6% -$122K 1.09% 22
2014
Q4
$20.6M Sell
197,342
-2,931
-1% -$309K 1.2% 19
2014
Q3
$21.3M Buy
200,273
+435
+0.2% +$45.1K 1.15% 24
2014
Q2
$20.9M Sell
199,838
-9,847
-5% -$995K 1.03% 25
2014
Q1
$20.6M Sell
209,685
-1,702
-0.8% -$158K 1.1% 25
2013
Q4
$19.4M Sell
211,387
-1,066
-0.5% -$98.2K 1.07% 24
2013
Q3
$18.4M Sell
212,453
-2,789
-1% -$250K 1.1% 20
2013
Q2
$18.5M Buy
+215,242
New +$18.3M 1.18% 20

Other funds holding JNJ

Ingalls & Snyder LLC's JNJ Position: Q1 2026 in Review

Ingalls & Snyder LLC reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q1 2026, selling an estimated $955K and leaving 74,952 shares worth $18.3M. The position accounts for 0.65% of the portfolio, ranked #36.

Ingalls & Snyder LLC first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.4M in Q4 2017. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ingalls & Snyder LLC held 74,952 shares of Johnson & Johnson worth $18.3M as of Q1 2026.
  • Ingalls & Snyder LLC sold 4,100 Johnson & Johnson shares in Q1 2026, an estimated $955K.
  • Johnson & Johnson made up 0.65% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #36 holding.
  • Ingalls & Snyder LLC first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Ingalls & Snyder LLC's Johnson & Johnson position peaked at $25.4M in Q4 2017.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.